Andere Kunden interessierten sich auch für
![In-hospital outcome of primary percutaneous coronary intervention]( "In-hospital outcome of primary percutaneous coronary intervention")
In-hospital outcome of primary percutaneous coronary intervention32,99 €![Importance of diabetes in patients who underwent coronary intervention]( "Importance of diabetes in patients who underwent coronary intervention")
Importance of diabetes in patients who underwent coronary intervention17,99 €![Role Of Biochemical Markers in Type 2 Diabetic Patients]( "Role Of Biochemical Markers in Type 2 Diabetic Patients")
Role Of Biochemical Markers in Type 2 Diabetic Patients40,99 €![Early Markers for Diabetic Nephropathy in Urine of Type 2 Diabetics]( "Early Markers for Diabetic Nephropathy in Urine of Type 2 Diabetics")
Early Markers for Diabetic Nephropathy in Urine of Type 2 Diabetics36,99 €![Major dietary patterns among patients with type 2 diabetes mellitus]( "Major dietary patterns among patients with type 2 diabetes mellitus")
Major dietary patterns among patients with type 2 diabetes mellitus40,99 €![Autonomic Neuropathy in Type 2 DM Patients in Enugu Nigeria]( "Autonomic Neuropathy in Type 2 DM Patients in Enugu Nigeria")
Autonomic Neuropathy in Type 2 DM Patients in Enugu Nigeria36,99 €![Risk of Foot Ulcer and its Determinants among Type 2 Diabetic Subjects]( "Risk of Foot Ulcer and its Determinants among Type 2 Diabetic Subjects")
Risk of Foot Ulcer and its Determinants among Type 2 Diabetic Subjects32,99 €
Diabetes mellitus and Cardiovascular diseases are two main chronic disorders that affect a large number of people worldwide. Type 2 Diabetic Patients have more adverse cardiovascular outcomes after Percutaneous Coronary Intervention (PCI) compared to non-diabetic patients. However, insulin-treated diabetic patients have even worse clinical outcomes compared to non-insulin treated diabetic patients. This research has compared the clinical outcomes between insulin treated and non-insulin treated diabetic patients after PCI. Moreover, type 2 diabetic patients tend to have platelet hyper-reactivity or dysfunction because of which, dual antiplatelet therapy (aspirin and clopidogrel) is not often sufficient after PCI. This research has also shown how adding cilostazol to this dual antiplatelet therapy (now considered as triple antiplatelet therapy) could benefit these diabetic patients after PCI.